# Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors \[RECIST\]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/alternative-response-criteria-choi-european-association-for-the-study-of-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Maxime Ronot,Mohamed Bouattour,Johanna Wassermann,Onorina Bruno,Chantal Dreyer,Béatrice Larroque,Laurent Castéra,Valérie Vilgrain,Jacques Belghiti,Éric Raymond,Sandrine Faivre |
| Citations | 157 |
| DOI | 10.1634/theoncologist.2013-0114 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://theoncologist.alphamedpress.org/content/19/4/394.full.pdf |
| OpenAlex ID | https://openalex.org/W2142020092 |
| PMID | 24652387 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Maxime Ronot](https://scholariq.org/researchers/maxime-ronot/)

## Paper journal

- [The Oncologist](https://scholariq.org/journals/the-oncologist/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.